119 related articles for article (PubMed ID: 22237433)
1. Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey.
Palomaki GE; Richards CS
Genet Med; 2012 Jan; 14(1):69-75. PubMed ID: 22237433
[TBL] [Abstract][Full Text] [Related]
2. Discrepancies in reporting the CAG repeat lengths for Huntington's disease.
Quarrell OW; Handley O; O'Donovan K; Dumoulin C; Ramos-Arroyo M; Biunno I; Bauer P; Kline M; Landwehrmeyer GB;
Eur J Hum Genet; 2012 Jan; 20(1):20-6. PubMed ID: 21811303
[TBL] [Abstract][Full Text] [Related]
3. Huntington Disease: Molecular Diagnostics Approach.
Bastepe M; Xin W
Curr Protoc Hum Genet; 2015 Oct; 87():9.26.1-9.26.23. PubMed ID: 26439718
[TBL] [Abstract][Full Text] [Related]
4. EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease.
Losekoot M; van Belzen MJ; Seneca S; Bauer P; Stenhouse SA; Barton DE;
Eur J Hum Genet; 2013 May; 21(5):480-6. PubMed ID: 22990145
[TBL] [Abstract][Full Text] [Related]
5. Results from an external proficiency testing program: 11 years of molecular genetics testing for myotonic dystrophy type 1.
Richards CS; Palomaki GE; Hegde M
Genet Med; 2016 Dec; 18(12):1290-1294. PubMed ID: 27253733
[TBL] [Abstract][Full Text] [Related]
6. Chorea Huntington: a rare case with childhood onset.
Gencik M; Hammans C; Strehl H; Wagner N; Epplen JT
Neuropediatrics; 2002 Apr; 33(2):90-2. PubMed ID: 12075490
[TBL] [Abstract][Full Text] [Related]
7. Development of genomic reference materials for Huntington disease genetic testing.
Kalman L; Johnson MA; Beck J; Berry-Kravis E; Buller A; Casey B; Feldman GL; Handsfield J; Jakupciak JP; Maragh S; Matteson K; Muralidharan K; Richie KL; Rohlfs EM; Schaefer F; Sellers T; Spector E; Richards CS
Genet Med; 2007 Oct; 9(10):719-23. PubMed ID: 18073586
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; HD gene and Huntington disease].
Maat-Kievit JA; Losekoot M; Roos RA
Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
[TBL] [Abstract][Full Text] [Related]
9. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
[TBL] [Abstract][Full Text] [Related]
10. Results of the College of American Pathology/American College of Medical Genetics and Genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population.
Feldman GL; Schrijver I; Lyon E; Palomaki GE;
Genet Med; 2014 Sep; 16(9):695-702. PubMed ID: 24577267
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility gene card for: Huntington's disease.
Saft C; Leavitt BR; Epplen JT
Eur J Hum Genet; 2014 May; 22(5):. PubMed ID: 24105375
[No Abstract] [Full Text] [Related]
12. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
Nahhas F; Garbern J; Feely S; Feldman GL
Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
[TBL] [Abstract][Full Text] [Related]
13. Two novel single-base-pair substitutions adjacent to the CAG repeat in the huntington disease gene (IT15): implications for diagnostic testing.
Margolis RL; Stine OC; Callahan C; Rosenblatt A; Abbott MH; Sherr M; Ross CA
Am J Hum Genet; 1999 Jan; 64(1):323-6. PubMed ID: 9915978
[No Abstract] [Full Text] [Related]
14. Normal CAG repeats in the Huntington gene in a family with benign familial chorea.
Meszaros K; Brücke T; Fuchs K; Gerhard E; Sieghart W; vanDer Meer CH; Aschauer HN
Psychiatr Genet; 1996; 6(2):91-4. PubMed ID: 8840396
[TBL] [Abstract][Full Text] [Related]
15. Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping.
Zhao M; Cheah FSH; Tan ASC; Lian M; Phang GP; Agarwal A; Chong SS
Sci Rep; 2019 Nov; 9(1):16481. PubMed ID: 31712634
[TBL] [Abstract][Full Text] [Related]
16. The neurology and natural history of patients with indeterminate CAG repeat length mutations of the Huntington disease gene.
Panegyres PK; Goh JG
J Neurol Sci; 2011 Feb; 301(1-2):14-20. PubMed ID: 21147489
[TBL] [Abstract][Full Text] [Related]
17. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
Zhao M; Lee CG; Law HY; Chong SS
Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
[TBL] [Abstract][Full Text] [Related]
19. Single-step scalable-throughput molecular screening for Huntington disease.
Teo CR; Wang W; Yang Law H; Lee CG; Chong SS
Clin Chem; 2008 Jun; 54(6):964-72. PubMed ID: 18403567
[TBL] [Abstract][Full Text] [Related]
20. DNA testing for Huntington disease in the Turkish population.
Akbas F; Erginel-Unaltuna N
Eur Neurol; 2003; 50(1):20-4. PubMed ID: 12824708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
